Ads
related to: NBIX- MarketWatch.com
MarketWatch Provides The Latest
Stock Market & Business News.
- Investing
See The News, Analysis And
Advice On Investing Here.
- Personal Finance
Read The Latest Stories On What The
Financial News Of The Day Means.
- Student Subscription
Subscribe to MarketWatch
Student All-Access Digital.
- MarketWatch.com
Search results
Decoding Neurocrine Biosciences Inc (NBIX): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 4 months agoNeurocrine Biosciences Inc (NASDAQ:NBIX) showcases a robust financial performance with INGREZZA net...
The Neurocrine Biosciences Inc (NBIX) Company: A Short SWOT Analysis
GuruFocus.com via Yahoo Finance· 7 months agoNeurocrine Biosciences Inc (NASDAQ:NBIX) shows strong revenue growth with a 28.6% increase in net...
The Make-Or-Break Moment Is Here For Highly Rated Neurocrine Biosciences
Investor's Business Daily· 2 years agoWall Street says it's make-or-break time for Neurocrine Biosciences' essential tremors treatment, as...
AMLX vs. NBIX: Which Stock Should Value Investors Buy Now?
Zacks via Yahoo Finance· 4 months agoInvestors with an interest in Medical - Drugs stocks have likely encountered both Amylyx...
Neurocrine Biosciences (NBIX) Earnings Expected to Grow: Should You Buy?
Zacks via Yahoo Finance· 2 years agoNeurocrine (NBIX) possesses the right combination of the two key ingredients for a likely earnings...
The $660 Million Opportunity That's Driving IBD Stock Of The Day Neurocrine Biosciences Higher
Investor's Business Daily· 8 months agoNeurocrine Biosciences is Tuesday's IBD Stock Of The Day. After unveiling promising results for a...
Neurocrine Biosciences is Under Heavy Accumulation, The One Chart that Matters
FX Empire via Yahoo Finance· 4 months agoNeurocrine Biosciences Stock Reveals Strong Demand Institutional volumes reveal plenty. For the past...
The Market Slumped Last Week; Why IBD Stock Of The Day Neurocrine Biosciences Didn't
Investor's Business Daily· 2 years agoNeurocrine Biosciences is the IBD Stock Of The Day as market uncertainty shakes plenty of leading...
Neurocrine Biosciences (NBIX) Reports Q2 Loss, Tops Revenue Estimates
Zacks via Yahoo Finance· 2 years agoNeurocrine (NBIX) delivered earnings and revenue surprises of -132.14% and 11.03%, respectively, for...
Blazing Hot Neurocrine Biosciences, With 40% Run This Year, Extends Breakout On Quarterly Beat
Investor's Business Daily· 2 years agoNeurocrine Biosciences handily beat Wall Street's third-quarter expectations Tuesday, leading NBIX...